Form 4/A for MAIA MAIA Biotechnology, Inc.

Accepted 2025-12-04 00:00:00 ET · period of report 2025-11-26 · accession 0001878313-25-000059 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MA	2025-12-04	2025-11-26+	MAIA	Vitoc Vlad	CEO, Dir, 10%	P - Purchase	$1.11	+72.0K	903.4K	+9%	+$80.1K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2025-11-26	P	A	22,000	$1.05	853,421	D	—	—	(F1) The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.0145 to $1.0587, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
2	Common	Common Stock	2025-11-28	P	A	50,000	$1.14	903,421	D	—	—	(F2) The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.1283 to $1.1416, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. (F3) The original Form 4 filed on December 1, 2025 had the incorrect total share balance owned by Vlad Vitoc. This Amended Form 4 is now reflecting the correct share balance owned.